Cleerly LABS vs A View LCS
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary need is a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely characterize atherosclerosis, quantify plaque volume and type, and assess stenosis. This tool is ideal for cardiologists focused on personalized heart disease management, tracking disease progression, and identifying ischemia with its dedicated module.
View Cleerly LABS →Choose A View LCS if…
Choose A View LCS if you require a comprehensive AI-powered platform for thoracic CT analysis, particularly for lung cancer screening, emphysema quantification, and opportunistic coronary artery calcification (CAC) scoring from a single low-dose CT scan. This solution is best suited for radiology departments or pulmonology practices aiming to efficiently screen for lung pathologies while also gaining valuable cardiovascular risk insights.
View A View LCS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | A View LCS |
|---|---|---|
| Pricing | Per analysis | Unknown |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS is a web-based application designed for a rich diagnostic user experience, offering an interactive platform for clinicians to review and interpret results with clear, actionable insights. While A View LCS offers flexible deployment options, Cleerly's emphasis on a streamlined, interactive web interface for detailed CCTA analysis suggests a more direct and refined user experience for its specialized function.
Clinical Value
Cleerly LABSCleerly LABS provides comprehensive, quantitative analysis of coronary plaque and ischemia, demonstrating improved diagnostic certainty, reduced downstream testing, and increased use of preventive medications. Its ability to offer a 3-in-1 assessment of atherosclerosis, stenosis, and ischemia, with abnormal findings linked to a 7-fold increase in adverse cardiovascular events, highlights its profound impact on personalized heart disease management and prevention. A View LCS also offers significant value in multi-organ thoracic analysis, but Cleerly's deep specialization in the leading cause of death and its proven influence on clinical decision-making gives it a slight edge.
Pricing & Value
Cleerly LABSCleerly LABS offers transparent pricing, detailing a per-analysis cost, current discounts, and information on insurance coverage and CPT codes. This transparency allows for a clear understanding of the investment and potential reimbursement. In contrast, A View LCS requires contacting for a quote, making it difficult to assess its pricing and overall value proposition upfront.
Enterprise Readiness
A View LCSA View LCS offers a broader range of deployment options, including cloud-based, hybrid, local on dedicated hardware, and locally virtualized solutions. This flexibility allows it to integrate more seamlessly into diverse enterprise IT infrastructures and accommodate various data governance requirements. Both tools are FDA-cleared, HIPAA compliant, and provide BAAs, but Tool B's versatile deployment gives it an advantage in enterprise adaptability.
Innovation
Cleerly LABSCleerly LABS is highly innovative for its advanced, quantitative characterization of coronary plaque (volume, type) and its focus on tracking disease progression to prevent heart attacks. It has received multiple prestigious awards, including 'Best Overall AI Solution' and 'Best Use of AI in Health Tech,' and was named one of TIME's World's Top HealthTech Companies. While A View LCS is innovative for its multi-organ analysis from a single low-dose CT, Cleerly's breakthrough approach to precision prevention in cardiovascular disease, backed by significant industry recognition, makes it the winner.
Support & Docs
Cleerly LABSCleerly LABS provides clear information on its client support availability, including specific hours (Monday-Friday, 10 am-6 pm ET) and a dedicated channel for technical assistance. It also offers accessible billing guidelines and indications for use documents. A View LCS lacks explicit details regarding direct customer support hours or a dedicated support portal, making Cleerly's support structure more transparent and readily accessible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | A View LCS |
|---|---|---|
| Product Name | Cleerly LABS | A View LCS |
| Primary Imaging Modality & Focus | Coronary CT Angiography (CCTA) for atherosclerosis and stenosis detection, quantification, and characterization. | Thoracic CT analysis for lung cancer screening, emphysema quantification, and coronary artery calcification detection. |
| Key Cardiovascular Analysis | Comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), personalized heart disease risk assessment, tracking disease progression over time. | Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass), segmentation of major coronary arteries. |
| Key Non-Cardiovascular Analysis | Not specified | Automated lung nodule detection and classification, nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting, emphysema analysis and quantification (LAA). |
| Reporting & Visualization | 3D visualization of coronary arteries, integration with PACS, RIS, EHR via Cleerly Proxy. | Automated comprehensive report generation (PDF, DICOM PDF, SR). |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and A View LCS.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or A View LCS
Backers
Who funded each tool's parent company.